AQR Capital Management »

4d Molecular Therapeutics In shares owned by AQR Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $312k 36k 8.69
2025-06-30 $97k 26k 3.71
2025-03-31 $46k 14k 3.23

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl A (GOOGL)
Verisign (VRSN)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Arista Networks Com Shs (ANET)
Palantir Technologies Cl A (PLTR)
PNC Financial Services (PNC)

View all positions for AQR Capital Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In